Researchers are conducting a clinical study to investigate whether cannabigerol (CBG)—a naturally occurring cannabinoid found in hemp—may help support individuals diagnosed with Attention‑Deficit/Hyperactivity Disorder (ADHD). ADHD is a common neurodevelopmental condition that can affect attention, impulse control, and executive functioning. This trial, registered with the U.S. National Institutes of Health, aims to gather controlled human […]
Tag: CBG
CBD and CBG as Adjunct Support for Trigeminal Neuralgia and Postherpetic Pain (pub. Oct. 2025)
Trigeminal neuralgia and postherpetic neuralgia are forms of neuropathic facial pain that can cause intense, persistent burning or stabbing sensations and are often difficult to manage with conventional medications alone. This clinical case report examined the use of cannabidiol (CBD) and cannabigerol (CBG) as supportive therapies in a patient whose symptoms did not respond adequately […]
How Hemp-Derived Cannabinoids Work in the Body: Why Formulation Matters (pub. July 2025)
Hemp-derived cannabinoids like CBD, CBG, CBC, and CBN don’t just differ in name—they also behave differently inside the body. When taken by mouth, these compounds are absorbed through the digestive system and can travel through the lymphatic system, which helps move fats and nutrients around the body. This pathway is important because it may help […]